Research Study
Pycnogenol® Reduces Risk of Post-Thrombotic Syndrome and Recurrent Thrombosis
![Pycnogenol® Reduces Risk of Post-Thrombotic Syndrome and Recurrent Thrombosis](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/food-beverage-nutrition/nutraingredients.com/product-innovations/pycnogenol-r-reduces-risk-of-post-thrombotic-syndrome-and-recurrent-thrombosis/8737205-1-eng-GB/Pycnogenol-R-Reduces-Risk-of-Post-Thrombotic-Syndrome-and-Recurrent-Thrombosis.png)
New research shows daily supplementation with Pycnogenol® may reduce the incidence of post-thrombotic syndrome (PTS) and recurrent thrombosis, a potentially life-threatening condition that may occur as a long-term complication of deep vein thrombosis (DVT). Pycnogenol® was shown to perform better than aspirin, ticlopidine and sulodexide in the treatment of DVT and PTS symptoms during the six year study.